000 01475 a2200409 4500
005 20250513201956.0
264 0 _c20000317
008 200003s 0 0 eng d
022 _a0006-8993
024 7 _a10.1016/s0006-8993(99)02133-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPozza, M
245 0 0 _aFurther evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution.
_h[electronic resource]
260 _bBrain research
_cFeb 2000
300 _a39-46 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute Disease
650 0 4 _aAnimals
650 0 4 _aBrain
_xenzymology
650 0 4 _aDemyelinating Diseases
_xenzymology
650 0 4 _aDisease Progression
650 0 4 _aEncephalomyelitis, Autoimmune, Experimental
_xdrug therapy
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGuanidines
_xpharmacology
650 0 4 _aNitric Oxide
_xphysiology
650 0 4 _aNitric Oxide Synthase
_xantagonists & inhibitors
650 0 4 _aRats
650 0 4 _aRats, Inbred Lew
650 0 4 _aSpecific Pathogen-Free Organisms
700 1 _aBettelli, C
700 1 _aAloe, L
700 1 _aGiardino, L
700 1 _aCalzà, L
773 0 _tBrain research
_gvol. 855
_gno. 1
_gp. 39-46
856 4 0 _uhttps://doi.org/10.1016/s0006-8993(99)02133-2
_zAvailable from publisher's website
999 _c10605166
_d10605166